CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Cellulitis - acute - How up-to-date is this topic?
Changes
Version 1.1, revision planned in 2012.
Last revised in September 2008
November 2008 — minor update. Co-amoxiclav added as an antibiotic option for treatment of mild facial cellulitis that does not require admission, in line with Health Protection Agency (HPA) recommendations [HPA and Association of Medical Microbiologists, 2008]. Issued in January 2009.
July to September 2008 — converted from PRODIGY guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.
Recommendations and prescriptions on recurrent cellulitis have been removed, as they are now considered out of scope. Other than this, there have been no major changes to the recommendations.
© NHS Institute for Innovation and Improvement